XML 64 R53.htm IDEA: XBRL DOCUMENT v3.8.0.1
INTANGIBLE ASSETS AND GOODWILL - Narrative (Details)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Oct. 01, 2016
USD ($)
Sep. 30, 2017
USD ($)
Dec. 31, 2016
USD ($)
Sep. 30, 2016
USD ($)
segment
Jun. 30, 2016
segment
unit
Sep. 30, 2017
USD ($)
segment
Sep. 30, 2016
USD ($)
Dec. 31, 2016
USD ($)
Aug. 31, 2016
USD ($)
Mar. 31, 2016
Dec. 31, 2015
USD ($)
Impairments                      
Net carrying amount   $ 16,023,000,000 $ 18,884,000,000     $ 16,023,000,000   $ 18,884,000,000      
Number of reportable segments | segment         2 3          
Percentage of fair value in excess of carrying value         15.00%            
Number of operating segments | segment       3   3          
Impairment $ 0     $ 1,049,000,000   $ 312,000,000 $ 1,049,000,000        
Goodwill   15,573,000,000 15,794,000,000     15,573,000,000   15,794,000,000     $ 18,553,000,000
Developed Markets                      
Impairments                      
Number of reporting units | unit         4            
Impairment           0          
Goodwill   0 0     0   0     16,141,000,000
Emerging Markets                      
Impairments                      
Number of reporting units | unit         3            
Impairment           0          
Goodwill   0 0     0   0     2,412,000,000
Bausch Lomb/International, Branded Rx, and U.S. Diversified Products                      
Impairments                      
Percentage of fair value in excess of carrying value 15.00%               15.00% 15.00%  
Impairment             211,000,000        
Goodwill       172,000,000     172,000,000        
Adjustment to goodwill     39,000,000                
Branded RX                      
Impairments                      
Percentage of fair value in excess of carrying value 8.00%               5.00%    
Impairment   312,000,000       312,000,000          
Goodwill $ 897,000,000 6,625,000,000 7,001,000,000     6,625,000,000   7,001,000,000 $ 897,000,000   0
Branded Rx and U.S. Diversified Products Segments                      
Impairments                      
Impairment       1,077,000,000              
Accumulated goodwill impairment loss   1,389,000,000       1,389,000,000          
U.S. Diversified Products                      
Impairments                      
Percentage of fair value in excess of carrying value         2.00%            
Impairment           0          
Goodwill   2,954,000,000 3,030,000,000     2,954,000,000   3,030,000,000     0
Developed Markets, Emerging Markets, U.S. Reporting Segments                      
Impairments                      
Impairment             838,000,000        
Goodwill       905,000,000     905,000,000        
Adjustment to goodwill     67,000,000                
Bausch Lomb / International                      
Impairments                      
Impairment           0          
Goodwill   5,994,000,000 5,763,000,000     5,994,000,000   5,763,000,000     $ 0
Salix                      
Impairments                      
Impairment 0         312,000,000   172,000,000      
Goodwill 5,128,000,000     5,128,000,000     5,128,000,000        
Aggregate purchase price 14,087,000,000     14,066,000,000     14,066,000,000        
Total identifiable net assets $ 10,319,000,000     $ 10,409,000,000     $ 10,409,000,000        
Salix | Developed Markets                      
Impairments                      
Impairment               0      
Salix | Emerging Markets                      
Impairments                      
Impairment               0      
Salix | Branded RX                      
Impairments                      
Impairment               172,000,000      
Salix | U.S. Diversified Products                      
Impairments                      
Impairment               0      
Salix | Bausch Lomb / International                      
Impairments                      
Impairment               0      
Other Product Lines                      
Impairments                      
Impairment of finite-lived intangible assets           73,000,000          
Uceris                      
Impairments                      
Impairment of intangible assets           0          
Net carrying amount   $ 619,000,000       619,000,000          
Product/patent assets                      
Impairments                      
Impairment of finite-lived intangible assets           86,000,000          
Acquired IPR&D                      
Impairments                      
Impairment of finite-lived intangible assets           3,000,000          
Held-for-sale                      
Impairments                      
Impairment of long-lived assets           115,000,000          
Held-for-sale | Sprout Pharmaceuticals, Inc.                      
Impairments                      
Impairment of long-lived assets           $ 352,000,000          
Adjustments                      
Impairments                      
Goodwill     0         0      
Adjustments | Developed Markets                      
Impairments                      
Goodwill     0         0      
Adjustments | Emerging Markets                      
Impairments                      
Goodwill     0         0      
Adjustments | Branded RX                      
Impairments                      
Goodwill     (264,000,000)         (264,000,000)      
Adjustments | U.S. Diversified Products                      
Impairments                      
Goodwill     0         0      
Adjustments | Bausch Lomb / International                      
Impairments                      
Goodwill     $ 264,000,000         $ 264,000,000